EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Review of Transcriptomic Biomarkers That Predict In Vitro Genotoxicity in Human Cell Lines

Heng-Hong Li iD, Jiri Aubrecht, Tatyana Y Doktorova, Danyel Jennen, J Christopher Corton iD, Roland Froetschl iD, Roman Mezencev, Carole L Yauk

Environmental and Molecular Mutagenesis · 2025

DOI: 10.1002/em.70004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Environmental and Molecular Mutagenesis, 2025. Verfasst von Heng-Hong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Georgetown University Medical Center, Washington, Washington, DC, USA. Hauptthemen laut MEDLINE: Transcriptome, Biomarkers, Mutagens. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current genotoxicity testing paradigm provides little mechanistic information, has poor specificity in predicting carcinogenicity in humans, and is not suited to assessing a large number of chemicals. Genomic technologies enable the characterization of genome‐wide transcriptional changes in response to chemical treatments that can inform mechanisms or modes of action. These technologies provided an impetus to develop transcriptomic biomarkers that could transform genotoxicity hazard assessment for drugs, cosmetics, and environmental and industrial chemicals. In August 2022, the International Workshops on Genotoxicity Testing (IWGT) held a workshop to critically review progress in the development and application of transcriptomic biomarkers in genotoxicity testing. Here, we describe the findings of this workshop's subgroup that conducted a systematized review and analysis of in vitro transcriptomic biomarkers for evaluating genotoxicity. Although there is a multitude of published reports exploring transcriptomics in genetic toxicology, the working group identified only five in vitro transcriptomic biomarker candidates, of which three (GENOMARK, TGx‐DDI, and MU2012) were independently developed with sufficiently defined context of use, validation data, and supporting case studies that warranted inclusion in the review. Although these in vitro biomarkers were developed independently and for different classes of chemicals (TGx‐DDI for pharmaceuticals, GENOMARK for cosmetics, and MU2012 for medical and environmental chemicals), they all address the same shortfall of the standard in vitro genotoxicity testing battery, that is, lack of specificity by genotoxicity‐induced stress response at the transcriptomic level. In this review, we discuss the development of these in vitro biomarkers, including challenges and progress toward achieving regulatory acceptance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscriptomeBiomarkersMutagensHumansMutagenicity TestsCell LineDNA Damage

Stichwörter der Autor:innen

DNA damage responseadverse outcome pathwaygenotoxicityp53transcript profilingtranscriptomic biomarker

Substanzen

BiomarkersMutagens

Autor:innen und Institutionen

  • Department of Oncology, Georgetown University Medical Center, Washington, Washington, DC, USA.
  • Predictive Modelling and Data Analytics, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Department of Translational Genomics, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
  • Center for Computational Toxicology and Exposure, US Environmental Protection Agency, Durham, North Carolina, USA.
  • Federal Institute for Drugs and Medical Devices, Bonn, Germany.
  • Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Washington, Washington, DC, USA.

ORCID-Profile: Heng-Hong Li, J Christopher Corton, Roland Froetschl

Förderung

  • NIEHS NIH HHS

Zitieren

APA

Li, H. H., Aubrecht, J., Doktorova, T. Y., Jennen, D., Corton, J. C., Froetschl, R., Mezencev, R., & Yauk, C. L. (2025). Review of Transcriptomic Biomarkers That Predict In Vitro Genotoxicity in Human Cell Lines. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.70004

Vancouver

Li HH, Aubrecht J, Doktorova TY, Jennen D, Corton JC, Froetschl R, et al. Review of Transcriptomic Biomarkers That Predict In Vitro Genotoxicity in Human Cell Lines. Environmental and Molecular Mutagenesis. 2025. doi:10.1002/em.70004

BibTeX
@article{Li2025,
  author = {Li, Heng-Hong and Aubrecht, Jiri and Doktorova, Tatyana Y and Jennen, Danyel and Corton, J Christopher and Froetschl, Roland and Mezencev, Roman and Yauk, Carole L},
  title = {Review of Transcriptomic Biomarkers That Predict In Vitro Genotoxicity in Human Cell Lines},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2025},
  doi = {10.1002/em.70004}
}
Kostenlos starten →